Home » Consulting Services » Pharmacy Software Development- Project Liaison »

Pharmacy Software Development- Project Liaison

When developing and implementing a new pharmacy-related software application, many organizations encounter challenges that result in a stalled project or one behind schedule. Typical issues encountered include the lack of resources with pharmacy and information technology expertise or the lack of focus on the project due to existing job responsibilities.

PHSL pharmacists are Subject Matter Experts (SME) that help software developers drive their project toward completion. PHSL understands how industry and legislative changes impact different business processes. PHSL consultants facilitate communication between business and IT professionals by efficiently interpreting business requirements and processes to facilitate guiding the project toward completion.

PHSL’s subject matter experts enable our clients to:

Deliver project results and meet deadlines
Reinvigorate a stalled project
Bridge the gap between the business owner and IT
Reduce project impact on day-to-day operations

View our case studies relating to our project liaison and subject matter experts:

Conversion from Multiple Platforms to a New Claims Processing System

Dispensing System Implementation

PHSI Tests Pharmacy’s Dispensing System Software

Successful Completion of Software Release due to PHSI Expertise

Software Developer Plans System Enhancements

May 2023 Question of the Month

Which type of project(s) could you or your organization most benefit from in 2023?

Future forecast: 0%

Competitor comparison: 20%

Contract variance analysis: 20%

Historical trend analysis: 20%

Legislative/regulatory impact: 0%

Procurement cost/savings: 20%

Stakeholder program impact: 20%

April 2023 Question of the Month

In July 2022, the FDA proposed expanding the NDC to a uniform 12 numeric digit format to accommodate future needs when all options using the current formats have been exhausted. Alternative options shared by the industry have asked the FDA to consider retaining the current NDC formats and allow the use of alpha characters when all numeric options have been exhausted.

Which of the following transition types is your organization prepared for in the next 5 years?

Make the transition to alphanumeric using the current NDC formats: 70%

Make the transition to the 12-digit numeric format: 20%

Make the transition to neither option: 10%

Make the transition to either option: 0%

March 2023 Question of the Month

What information would you most like to gain from an Online Listening Assessment for a particular drug therapy or device? (Multiple selections allowed)

Prescribing & Dispensing Concerns: 25%

Competitor Comparisons: 25%

Prescribing Information Alignment: 17%

Coverage & Reimbursement: 17%

Patient Affordability: 8%

Misinformation: 8%

Disease State Concerns: 0%